Medical Mycology

Article	Citations
Development of in-house ELISA for Scedosporium/Lomentospora serodiagnosis	38
Knowledge and regulation on fungal contamination of sand and water: Progress report and perspectives	37
Evaluation of the drug–drug interaction between triazole antifungals and cystic fibrosis transmembrane conductance regulator modulators in a real-life cohort	35
Epidemiology and susceptibility of Nakaseomyces (formerly Candida) glabrata bloodstream isolates from hospitalised adults in South Africa	31
Novel in vivo observations of luliconazole 5% nail solution for onychomycosis: An ultrastructural study	30
The combination of manogepix and itraconazole is synergistic and inhibits the growth of Madurella mycetomatis in vitro but not in vivo	27
Clinical characteristics and outcomes of pancreatic fungal infection in patients with necrotizing pancreatitis	26
P422 EQUAL PCP Score 2022—an ECMM score derived from current guidelines to measure QUAlity of clinical Pneumocystis Pneumonia management	25
Comparison of virulence factors and susceptibility profiles of Malassezia furfur from pityriasis versicolor patients and bloodstream infections of preterm infants	23
S5.1b Antifungal r esistance	23
P049 Candidemia: Isolate profiling and antifungal susceptibility testing experience from Jodhpur, Western India	22
S2.2d Evaluation of new tools for the diagnosis of histoplasmosis	21
P216 Rare isolates from subcutaneous mycotic lesions; A study from tertiary care center in Chhattisgarh, India	21
P373 Does biofilm forming capacity of Candida tropicalis vary with echinocandin susceptibility?	21
Invasive fungal infections in patients with haematological malignancies at the University Hospital of Reunion Island (2018–2022): An observational study	21
P196 A rare presentation of subcutaneous Entomophthoramycosis	20
P361 Demystifying the NIH grant application process for international investigators	19
S7.2d Divergent EGFR/MAPK-mediated immune responses to clinical Candida pathogens in vulvovaginal candidiasis	18
P335 Genome plasticity in Candida albicans : acutting-edge strategy for evolution, adaptation, and survival	18
S6.5c MycetOS: identifying drugs which can penetrate the mycetoma grain	18
P020 Risk factors, speciation ,and antifungal susceptibility in candidemia patients: An observational study	17
Fungal diagnostics capacity in Malaysia: A survey across 48 laboratories	17
S1.3c Diversity and hybridization in Malassezia furfur	17
Prevalence of azole-resistant Aspergillus fumigatus and other aspergilli in the environment from Argentina	17
P019 A 5-year study on prevalence and molecular determinants of fluconazole -resistance in C. parapsilosis spp. complex	17

Landscape of in situ cytokine expression, soluble C-type lectin receptors, and vitamin D in patients with recurrent vulvovaginal candidiasis	17
Investigation of CryptoPS LFA-positive sera in patients at risk of cryptococcosis	16
A global perspective of the changing epidemiology of invasive fungal disease and real-world experience with the use of isavuconazole	15
OUP accepted manuscript	15
A 40-year antifungal susceptibility surveillance of Talaromyces marneffei (1984–2024) at a tertiary hospital in Guangxi, China	15
Superficial fungal infections in the south of France—is fusariosis the next emergent onychopathy?	15
Mycology laboratory diagnostic capacity for invasive fungal diseases in public hospitals in Vietnam	14
Identification and antifungal susceptibility profile of uncommon yeast species at Fattouma Bourguiba University Hospital in Tunisia	14
P348 tRNA modifications in Candida virulence	13
P478 Identification of clinical Candida isolates using maldi-tof-ms and their antifungal susceptibility profile—a study from tertiary care pediatric hospital in noida	12
P212 Fatal invasive aspergillosis in a child with Chronic Granulomatous disease; a case report	12
P086 Clinical outcome and in vitro antifungal susceptibility of clinical isolates of rhino-orbito-cerebral mycosis associated with post COVID 19 from North India	12
P088 Molecular identification and antifungal susceptibility of pathogenic yeasts from the China Antifungal Resistance Surveillance Trial (CARST-fungi) Study	12
S2.2a African histoplasmosis	12
S3.4e Unraveling the role of DOG genes in a novel alternative pathway of glycerol biosynthesis in Candida albicans and its influence on virulence	12
P192 Investigating the link between pleomorphism and virulence in Cryptococcus	12
P466 Isolation of Cryptococcus neoformans and other yeast from pigeon droppings in Khartoum state, Sudan	12
S8.3d Characterization of glycosylphosphatidylinositol-linked aspartyl proteases in Candida glabrata: Role in pathogenicity	12
P355 Pitfalls in medical mycology in India	11
P148 Emerging and cryptic Aspergillus species isolated from hospitalized patients with underlying primary immunodeficiencies	11
P382 Scalp fungal microbiome and sebum composition in males with and without androgenetic alopecia	11
P344 Automatic detection of pneumocystis jirovecii in microscope images: adeep learning-based approach	11
S10.4c Successful treatment of mucormycosis in hematological diseases	11
P309 Clonal outbreak of Trichophyton tonsurans causing tinea capitis among wrestlers in Beijing, China	11
S1.3d The human pathobiont Malassezia furfur secreted protease MfSAP1 regulates cell dispersal and exacerbates skin inflammation	11
S10.5c Insight into the role of secondary metabolism in the pathogenesis of Scedosporium apiospermum	11
Cytokine response as a biomarker for early diagnosis and outcome prediction of stem cell transplant recipients and acute leukemia patients with invasive aspergillosis	10
Virulence is one of the mechanisms of vulvovaginal candidiasis recurrence, rather than drug resistance	10
Effects of the Novel Mitochondrial Targeted Compound Phosundoxin against Sporothrix globosa: Microbial Sensitivity Test combined with Transcriptomics and Proteomics	10
Antifungal efficacy of natural antiseptic products against Candida auris	10
S5.5d SARS-CoV-2 associated invasive fungal sinus infections; the Sri Lankan perspective	10
S4.5a A randomized, double blind phase II proof-of-concept superiority trial of fosravuconazole 200 mg or 300 mg weekly dose versus itraconazole 400 mg daily, all three arms in combination with surger	10
S9.5d Genotyping of Malassezia species from seborrheic dermatitis/dandruff patients	10
Predicting intracranial involvement: Unveiling perineural spread in COVID-19-associated mucormycosis, a novel phenomenon	10
P094 Atypical cutaneous manifestations of sporotrichosis in Brazil	10
P303 An unusual case of isolated gluteal abscess	9
P345 The relationship between virulence of Candida albicans and environmental oxygen concentration	9
Bronchial aspirate obtained during bronchoscopy yields increased fungal load compared to bronchoalveolar lavage fluid in patients at risk of invasive aspergillosis and Pneumocystis pneumonia	9
P193 Candidemia in coronavirus disease 2019 patients in a university hospital in Buenos Aires, Argentina	9
Aspergillus sensitisation detection using point-of-care lateral flow assay in moderate to severe asthma	9
Antibodies against Histoplasma capsulatum and Aspergillus fumigatus among chronic TB patients in Indonesia: a cross-sectional study	9
P183 Monitoring of candida colonization in the respiratory tract of COVID-19 cases	9
P420 Fungal detection by means of HCR using 2D-Covalent Organic Framework Nanosheet	9
S5.1d Mechanisms of azole antifungal resistance in clinical isolates of Candida tropicalis	9
P225 Subcutaneous phaeohyphomycosis by Phaeoacremonium species in a renal transplant recipient	9
P114 Clinical and microbiological spectrum of dermatophytosis from a tertiary care institute	9
Candida glabrata (Nakaseomyces glabrata): A systematic review of clinical and microbiological data from 2011 to 2021 to inform the World Health Organization Fungal Priority Pathogens Lis	9
S4.1d In vitro activity of eight antifungals against 3343 filamentous pathogenic fungi collected during 18 years at the French National Reference Center for invasive mycosis and antifungals	9
Detection and genotyping of zoonotic microsporidia in the endangered Iberian lynx (Lynx pardinus)	9
P411 Genus specific real-time PCR-a promising technique for rapid diagnosis of fungal keratitis	9

Malassezia japonica isolated from the cerumen of Cercopithecidae and Hylobatidae	9
Whole genome characterization of Trichophyton indotineae isolated in Singapore	8
P291 Aspergillosis: another force to reckon with during COVID-19 times	8
Time-to-positivity in bloodstream infection for Candida species as a prognostic marker for mortality	8
Performance of Fungitell STAT point-of-care test for the diagnosis of invasive fungal diseases	8
Evaluation of a commercial Histoplasma antigen detection enzyme immunoassay for the follow-up of histoplasmosis treatment in people living with HIV from Argentina	8
Management of disseminated histoplasmosis in a high-complexity clinic in Cali, Colombia	8
Evaluation of direct antifungal susceptibility testing using E-test for four antifungal agents in candidemia patients	8
Evaluation of the PneumoGenius® PCR assay for the diagnosis ofPneumocystispneumonia and the detection ofPneumocystisdihydropteroate synthase mutations in respiratory samples	8
P118 Pentraxin-3 interacts with Aspergillus fumigatus conidia to regulate pro-inflammatory cytokine production	8
S6.3d Candida albicans commensalism in the oral mucosa is favored by limited virulence and metabolic adaptation	8
P113 Expression profile of ABC and MFS multi-drug transporter genes in terbinafine- and fluconazole-resistant Trichophyton spp.	8
Opaque cell-specific proteome ofCandida albicansATCC 10231	8
P313 A retrospective analysis of COVID-19 - associated Mucormycosis in a tertiary care center in Northern India	8
Diagnostic accuracy of a novel lateral flow assay for histoplasmosis	8
S5.4d Agrochemicals potentiate multidrug resistance and alter virulence in Cryptococcus neoformans via hitch-hiking effect of aneuploidy	7
P131 Optimization of MTT assay protocol in Pythium insidiosum zoospores incubated together with neutrophils	7
Molecular typing and antifungal susceptibility of clinical isolates of Cryptococcus neoformans and Cryptococcus gattii species complexes from the National Invasive Fungal Surveillance Ne	7
P166 Traumatic implantation keratitis with Schizophyllum commune in Central India	7
S2.4d Combination antifungal effects of eugenol with voriconazole against Candida tropicalis and Candida krusei strains isolated from the genital tract of mares	7
Spectrum of clinically significant melanized fungi in NIH hospitalized patients and their antifungal susceptibility profiles	7
Risk factors for COVID-19 associated mucormycosis in India: A case control study	7
Evaluation of interleukin-8 levels in the diagnosis of invasive pulmonary aspergillosis in patients with haematological malignancies	7
P256 A rare case of co-infection with Nigrospora oryzae with mucormycosis in an immunocompromised post-COVID patient	7
S9.5c Malassezia-host interactions and the Il-23/17 axis	7
P018 Susceptibility profile of Candida albicans causing bloodstream infections against azole antifungals over 5 years: A prospective observational study	7
S3.5a Contamination in sand and water of sea, lakes, and river beaches: Risk factor for fungal human disease	7
Dual quantitative PCR assays for the rapid detection of Trichophyton indotineae from clinical samples	7
Feline sporotrichosis caused by Sporothrix schenckii sensu stricto in Southern Thailand: phenotypic characterization, molecular identification, and antifungal susceptibility	7
Clinical and imaging characteristics of pulmonary cryptococcosis: a comparative analysis of 118 non-AIDS patients in China	7
S8.1b Is a search and destroy strategy still feasible for Candida auris in South Africa?	7
Clinical characteristics and outcome of invasive fungal sinusitis in children with hematological malignancies	7
P435 Evaluation of remote triazole capillary blood testing to facilitate remote therapeutic drug monitoring (TDM): A validation study	7
Zoonotic Enterocytozoon bieneusi genotypes in free-ranging and farmed wild ungulates in Spain	7
A practical approach to investigating nosocomial acquisition of Aspergillus	7
S7.4a Vaccine-inducing lung resident CD4 + memory T cells are protective against Cryptococcus gattii infections	6
Thanks to Reviewers	6
P299 A clinicomycological study of suspected mucormycosis in post-COVID patients attending a tertiary care hospital	6
P372 Deciphering transcript isoform switching and utilization in mature biofilm of Candida glabrata through a global transcriptomic approach	6
Evaluation of an in-house pan-Malassezia quantitative PCR in human clinical samples	6
P334 Fungal infections in patients with COVID-19 in 1-year pandemic 2020-2021 from Cote d'Ivoire	6
P414 Diagnostic allele-specific PCR for the identification of Candida auris clades and common resistance mutations	6
Biochemical characterization and analysis of gene expression of an α-mannosidase secreted by Paracoccidioides brasiliensis	6
P317 Phaeohyphomycosis caused by Phialophora verrucosa in a patient with CARD9 mutations	6
P068 Inhibition of Candida glabrata biofilm using the combination of a novel antifungal cyclic lipopeptide and azole: An in vitro synergistic approach	6
Molecular detection of Enterocytozoon bieneusi in bats from Portugal	6
Significance of differential expression profiles of ABC transporters in azole susceptibility between Cryptococcus gattii VGI and VGII strains	6
P438 Epidemiology, risk factor analysis and management of invasive Candida auris infections in tertiary care hepatobiliary center in India	6
P233 COVID-19-a ssociated Mucormycosis: an experience of invasive fungal sinusitis from a tertiary care referral center in Northern India	6
P364 Quantitative monitoring of Aspergillus fumigatus mycelial growth by optical density	6
Value of qPCR in the screening strategy for Candida auris	6
P502 Mycology lab of the future—slants to sequencing	6
P110 AIRE gene mutation predisposing chronic mucocutaneous Candidiasis in two kids from a Chinese family	6
A notable azole-nonsusceptible Candida orthopsilosis in the Candida parapsilosis complex isolated from onychomycosis in Hue City, Central Vietnam	5
P206 Phenotypic and molecular characterization of emerging Basidiomycete Schizophyllum commune isolated from clinical samples from India	5
P486 Disseminated Cryptococcosis diagnosed on fine needle aspiration cytology	5
Impact of COVID-19 on the antifungal susceptibility profiles of isolates collected in a global surveillance program that monitors invasive fungal infections	5
Assessing the safety profile of voriconazole use in suspected COVID-19-associated pulmonary aspergillosis–a two-centre observational study	5
Post-COVID-19 rhino-orbito-cerebral mucormycosis—A clinico-mycological study from North India	5
S1.5d Spectrum of etiological agents of mycotic keratitis: A n 11- year review	5
P171 Pneumocystis Jirovecii Pneumonia in non-HIV immunosuppressed patients: Acase series	5
Mortality patterns in candidemia: Insights from a multispecies analysis using a global research network	5
Species and antifungal susceptibility profile of agents causing vulvovaginal candidiasis in a military population: a cross-sectional study	5
P432 Detection of erg11 gene mutation in fluconazole resistant Candida albicans isolates	5
Coccidioidesspp. exposure among military working dogs in endemic regions of the United States	5
P391 Research on molecular diagnostic methods and clinical application of common pathogenic dermatophytes in tinea capitis	5
P501 Aspergillus fumigatus complicates one third of the patients with suspected bronchial asthma or pulmonary tuberculosis: Clinical validation of indigenously developed diagnostic kits	5
Mucorales: A systematic review to inform the World Health Organization priority list of fungal pathogens	5
P474 The value of PCR-based azole resistance detection in invasive aspergillosis: A prospective multicenter study	5
Routine laboratory screening for cyp51a-related azole resistance in Aspergillus fumigatus using Etest: Concordance with gene sequencing	5
Deep Learning for the Identification of Candida spp. Directly from Blood Culture Gram Stains from Candidemia Patients	5
The evolution of HIV-associated cryptococcal meningitis in Uganda from 2010 to 2022	5
Epidemiological shifts of invasive fungal infections in the current era of haematology	5
P223 First case of Candida auris candidemia in Manipur, Northeast India	5
A diverse spectrum of mycoses histologically diagnosed in Ghana: Insights from a 10-year retrospective study	5
P273 Diagnostic dilemmas in Pneumocystis pneumonia in case of long COVID -19	5
Exposure to itraconazole influences the susceptibility to antifungals, physiology, and virulence of Trichophyton interdigitale	5
Identification of four compounds from the Pharmakon library with antifungal activity against Candida auris and species of Cryptococcus	5
P057 All- cause mortality in patients with invasive Candidiasis or candidemia from an interim analysis of a Phase 3 Open-label Study (FURI)	5
S9.1d Chronic pulmonary aspergillosis in post-TB and retreatment TB patients in Lagos, Nigeria	5

Cost-effectiveness of single-dose AmBisome pre-emptive treatment for the prevention of cryptococcal meningitis in African low and middle-income countries	5
P294 A descriptive study of Trichosporon fungemia cases from tertiary care center from north India	5
Exploring virulence attributes in non-Cryptococcus Tremellomycetes	4
P135 Immunological correlation with clinicomycological aspects of fungal rhinosinusitis during COVID-19 pandemic	4
S6.2d Dermatophytosis due to Trichophyton erinacei caused by contact with African hedgehogs as family pets	4
P211 Fungal and bacterial co-infections of the respiratory tract among patients with COVID-19 hospitalized in intensive care units	4
Identification of potential targets in bone destruction by Talaromyces marneffei: Insights from data-independent acquisition proteomics	4
Evaluation of simple molecular methods for distinction of the newly emerging dermatophyte Trichophyton indotineae	4
Gastrointestinal tract Candida spp colonization shows mostly a monoclonal pattern: an intra-patient pilot study	4
P371 The relation of mating type (MAT) preference and source in the opportunistic pathogen Talaromyces marneffei	4
P395 Clinical utility of semi-nested conventional PCR for diagnosis of mucormycosis in fresh clinical samples	4
Performance of the beta-glucan test for the diagnosis of invasive fusariosis and scedosporiosis: a meta-analysis	4
P328 An overexpression screen identifies Csa25 as a novel cellular morphogenesis regulator in the human fungal pathogen Candida albicans	4
Aspergillus fumigatus—a systematic review to inform the World Health Organization priority list of fungal pathogens	4
KL-6 as a predictor of coronavirus disease 2019 (COVID-19)-associated pulmonary aspergillosis (CAPA) and mortality in critically ill COVID-19 patients: A single-center retrospective cohort study	4
P078 Baseline antifungal usage patterns and knowledge regarding management of invasive fungal infections as a part of a multidisciplinary antifungal stewardship (AFS) program	4
Vaginal homeostasis features of Vulvovaginal Candidiasis through vaginal metabolic profiling	4
Octyl gallate as a treatment for Candida albicans-induced vaginal infection: Effects on fungal burden, inflammation, and Lactobacillus recovery in mice	4
Evaluation of formic acid sandwich (FA-sandwich): A pretreatment method for filamentous fungi, for the identification of clinically relevant filamentous fungi by two MALDI-TOF MS systems	4
P326 DNA replication initiator proteins stabilize the kinetochore in the human fungal pathogen Cryptococcus neoformans	4
P251 Disseminated Histoplasmosis in a Ghanaian HIV Patient: Role of Urine Histoplasma Antigen Testing in Rapid Diagnosis	4
S10.5a Fungal respiratory infections in cystic fibrosis patients in the Middle East	4
Malassezia gallinae sp. nov., a new basidiomycetous yeast species isolated from skins of chickens	4
The Argentinian landscape of mycological diagnostic capacity and treatment accessibility	4
High histoplasmosis incidence in kidney transplant recipients in Santa Fe city, Argentina	4
Comparison of PneumID real-time PCR assay with Amplex eazyplex LAMP assay for laboratory diagnosis of Pneumocystis jirovecii Pneumonia	4
Epidemiology of candidemia during COVID-19 pandemic era in a teaching hospital: A non-concurrent cohort study	4
P032 Efficacy of novel azole compounds (ATTAF-1 and ATTAF-2) against Candida albicans in a murine model of invasive Candidiasis	4
Investigation of invasive fungal infection in tuberculosis/human immunodeficiency virus co-infected patients	4
Cryptococcosis in domestic and wild animals: A review	4
Closing the diagnostic gap in medical mycology: The LODDY Test for identification of Lodderomyces elongisporus	4
P217 Pelvic mycoses— an unusual presentation of Rhizopus arrhizus in an ommunocompetent patient	4
P154 Fungal spore count in a tertiary care hospital in Mumbai, India	4
P337 Species distribution and biofilm profile of Candida isolated from clinical specimens at a tertiary care hospital in India	4
P383 ‘It's not Fungus, its Nocardia’—an elementary diagnostic challenge for draining sinus on abdominal wall (rare): a case report	4
Perspective on receptor-associated immune response to Candida albicans single and mixed infections: Implications for therapeutics in oropharyngeal candidiasis	4
P370 Low rate of Sporothrix spp. recovery from storage in mineral oil: along period study	4
P269 Managing prosthetic valve endocarditis due to Sarocladium kiliense: Finding a way through uncertainties	3
S9.4c Diverse environmental inputs mediate changes in β-glucan exposure at the Candida albicans cell surface thereby influencing tissue colonisation during systemic infection	3
Atovaquone exposure and Pneumocystis jirovecii cytochrome b mutations: French data and review of the literature	3
P054 Two effects of curcumin to Candida albicans	3
Incidence of invasive fungal infections in patients with hematological malignancies receiving ibrutinib therapy in south-east Austria	3
P167 Fungemia in neonatal ICU of a pediatric hospital in NE India	3
P268 Laryngeal Mucormycosis: does mucor take the voice away?	3
Identification of the cell-surface lectin domain-containing protein expressed in the adhesive colony morphology of Trichosporon asahii	3
Effectiveness of diphenyl diselenide against experimental sporotrichosis caused by Sporothrix brasiliensis	3
P426 Interleukins—a non-invasive biomarker for invasive fungal sinusitis	3
Natural history of pulmonary coccidioidomycosis: Further examination of the VA-Armed Forces Database	3
P041 Preliminary evaluation of gradient concentration strips for detection of terbinafine resistance in Trichophyton spp.	3
P075 Initial results of an international effort in screening new agents against Candida auris	3
P458 Comparison of PCR protocols for detecting Histoplasma capsulatum and Coccidioides spp. DNA through a multicenter study	3
The Billirud Mill Blastomycosis Outbreak: Comparison to Historical Controls	3
P051 A case of recalcitrant sporotrichosis by infection of Sporothrix globosa	3
P219 Fungal keratitis caused by Pseudallescheria boydii: Clinical and mycological characteristics	3
P106 A dermoscopic finding of Tinea capitis caused by Microsporum canis	3
P195 Factors related to outcome of bloodstream infections due to Candida parapsilosis complex: A single center observation study from Central India	3
P442 Bacterial and fungal infection in COVID-19 diagnosed cases in a tertiary care ICU setting in the wake of second wave in Kolkata, India	3
A Falciformispora senegalensis grain model in Galleria mellonella larvae	3
P138 A decade of cat-transmitted sporotrichosis (CTS) in a tertiary hospital from Curitiba, southern Brazil (2011-21)	3
Madurella mycetomatis grains within a eumycetoma lesion are clonal	3
S1.4d Cryptococcus qPCR assays: the future for routine mycology labs and clinical trials dealing with cryptococcosis	3
Metabolic and morphostructural plasticity of environmental and animal strains of Nannizzia gypsea	3
P417 Evaluation of matrix-assisted laser desorption ionization time-of-flight mass spectrometry (MALDI-TOF MS)-Bruker Biotyper Sirius for identification of invasive molds	3
Experimental Pneumocystis infection in dexamethasone immunosuppressed macaques	3
S6.2b In vitro susceptibility testing of dermatophytes: toward standardization	3
Deciphering prognostic indicators in non-HIV cryptococcal meningitis: Constructing and validating a predictive Nomogram model	3
P240 Candida nivariensis infection in South East Asia: series of case reports from Selayang Hospital, Malaysia and South East Asia Region	3
P044 Demonstration of the yeasticidal efficacy of povidone-iodine-based commercial antiseptic solutions against Candida auris	3
Talaromyces marneffei, Coccidioides species, and Paracoccidioides species—a systematic review to inform the World Health Organization priority list of fungal pathogens	3
P174 Prevalence and outcomes of patients with COVID - associated mucormycosis (CAM): A case series	3
P213 Lasiodiplodia theobromae: an emerging human pathogen	3
P484 Expanding VGVI—evidence for distinct Cryptococcus gattii (decagattii) endemic to the American Southwest	3
Interference of Malassezia restricta in the invasion of Staphylococcus aureus into human keratinocytes	3
P399 Diagnostic value of Candida coloni zation index and serum Candida mannan antigen for candidemia in febrile episodes of pediatric lymphoreticular malignancies	2
Development and validation of a new quantitative reverse transcription PCR assay for the diagnosis of human sporotrichosis	2
P124 Cryptococcus neoformans-and Cryptococcus gattii-specific antibodies vary among children and adults with cryptococcosis and healthy from Colombia	2
Clinical utility of pharmacogenomic testing for patients with coccidioidal meningitis	2
High prevalence of central nervous system cryptococcosis using a fingerprick whole-blood lateral flow assay in individuals with neurological symptoms and advanced HIV disease in a Brazilian emergency	2
Reactive oxygen and nitrogen species are crucial for the antifungal activity of amorolfine and ciclopirox olamine against the dermatophyte Trichophyton interdigitale	2
Microbial and clinical epidemiology of invasive fungal rhinosinusitis in hospitalized COVID-19 patients, the divergent causative agents	2
S7.1d Reliability of bedside point-of-care tests for Candida neoformans , M. tuberculosis and S. pneumoniae in adults living with HIV presenting with suspected central nervous sys	2
The need for fast and accurate detection of dermatomycosis	2
S3.4c A pipeline toward the identification of novel antifungal compounds derived from the microbial dark matter	2
P425 Approach to identify and isolate C. dubliniensis in laboratory and comparison of various methods for same	2
P242 Autochthonous cases of Madura foot from Jodhpur, Western Rajasthan, India	2
Is milbemycin a game changer against antifungal drug-resistant mycoses?	2
Deubiquitination module is critical for oxidative stress response and biofilm formation in Candida glabrata	2
Molecular typing and antifungal susceptibility profile of Candida krusei bloodstream isolates from Türkiye	2
P260 Sporotrichosis hyperendemic in Southern Brazil: twelve years of challenges	2
Aflatoxin profiles of Aspergillus flavus isolates in Sudanese fungal rhinosinusitis	2
P231 The first case of neonatal fungemia caused by Aureobasidium melanogenum	2
Molecular identification of Fonsecaea pedrosoi in chromoblastomycosis: Insights from paraffin-embedded human skin biopsies and clinicopathology	2
S3.4d The role of NLRP3 inflammasome in host defense during Talaromyces marneffei infection	2
Invasive mold infection of the gastrointestinal tract: A case series of 22 immunocompromised patients from a single academic center	2
Detection of Blastomyces gilchristii via metagenomic sequencing in outbreak-associated soils	2